We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




PET Technique Detects Bacterial Infections

By MedImaging International staff writers
Posted on 16 Oct 2017
Print article
Image: Mice with a P. aeruginosa-infected wound (left) and control mice (right), and sagittal slices from a micro PET/CT scan one hour after administration of the new tracer (Photo courtesy of Sam Gambhir, MD, PhD, Stanford University).
Image: Mice with a P. aeruginosa-infected wound (left) and control mice (right), and sagittal slices from a micro PET/CT scan one hour after administration of the new tracer (Photo courtesy of Sam Gambhir, MD, PhD, Stanford University).
A new non-invasive PET imaging technique has been developed that can detect bacterial infections, and monitor antibiotic therapy.

Bacteria are developing antibiotic resistance by mutating, and this has led government healthcare authorities to call for the development of new diagnostic techniques that can detect and help manage infectious diseases.

The scientists from the Stanford University (Stanford, CA, USA) published their research, part of a pre-clinical study, in the October 1, 2017, issue of The Journal of Nuclear Medicine.

The researchers developed a new Positron Emission Tomography (PET) tracer called 6"-18F-fluoromaltotriose that is derived from maltose, labeled with radioactive fluorine-18 (18F), and evaluated it with a number of clinically-relevant bacterial strains, and a micro-PET/CT scanner.

The results show that both gram-negative, and gram-positive bacteria took up the new tracer, and that the tracer could be used to diagnose most bacterial infections, and could change the clinical management of bacterial infectious diseases in patients.

Sanjiv Sam Gambhir, MD, PhD, Stanford University, said, "The hope is that in the future when someone has a potential infection, this approach of injecting the patient with fluoromaltotriose and imaging them in a PET scanner will allow localization of the signal and, therefore, the bacteria. And then, as one treats them, one can verify that the treatment is actually working – so that if it's not working, one can quickly change to a different treatment (for example, a different antibiotic). These kinds of findings are very important for patients, because they will very likely lead to entirely new ways to manage patients with bacterial infections, no matter where those infections might be hiding in the body."

Related Links:
Stanford University

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
X-Ray Detector
FDR-D-EVO III
New
Digital Radiography Generator
meX+20BT lite
New
PACS Workstation
CHILI Web Viewer

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.